Newsroom

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports the following information relating to the year ended December 31, 2025. Further details concerning the results of operations as well as other matters are available in Retractable’s Form 10-K filed on March 27, 2026 with the U.S. Securities and Exchange Commission. The Company’s revenues for 2025 increased 15.8%. The Company’s revenues were approximately $38.3 million in 2025 as compared to approximat...

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of ImmunityBio, Inc. (“ImmunityBio” or the “Company”) (NASDAQ: IBRX) on behalf of investors concerning the Company’s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON IMMUNITYBIO, INC. (IBRX), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On March 24, 2026, Bloomberg reported that ImmunityBio had receiv...

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, has announced that the Company has granted an aggregate of 97,674 Deferred Share Units (“DSUs”) to four of its non-employee directors that elected to receive all or a portion of their annual directors’ fees for fiscal year 2026 in DSUs as opposed to cash. The DSUs were granted under the Company's Amended and Restated Omnibus Long-Term...

NEW YORK--(BUSINESS WIRE)--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against ImmunityBio, Inc. (“ImmunityBio” or the “Company”) (NASDAQ: IBRX) and reminds investors of the May 26, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm...

MIAMI--(BUSINESS WIRE)--On March 27, 2026, the Fairholme Focused Income Fund (“FOCIX” or the “Fund”) distributed an Ordinary Income dividend of $0.07347 per share to shareholders of record as of March 26, 2026. The Fund’s Net Asset Value (“NAV”) was reduced by the amount of the distribution. The Record Date, Ex-Dividend Date, Payable Date, and Cents-Per-Share are as follows: THE FAIRHOLME FOCUSED INCOME FUND   Distribution Type Record Date Ex-Dividend Date Payable Date Cents-Per-Share Ordinary...

SCOTTSDALE, Arizona--(BUSINESS WIRE)--Axway, una empresa de 74Software (Euronext: 74SW) y líder internacional en gestión federada de API e integración empresarial, ha recibido el reconocimiento de líder en el informe IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify conecta, coordina y automatiza de forma segura la integración de datos. Empresas de los sectores de servicios financieros, fabricación, salud y otros confían en Amplify para modernizar sus integracione...

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (“Retractable”) (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning January 1, 2026 through March 31, 2026. The dividends will be paid on April 20, 2026 to...

WARSZAWA, Polska--(BUSINESS WIRE)--Polska Agencja Inwestycji i Handlu (PAIH) przyznała projektowi Apex 2 firmy Ascend Elements tytuł inwestycji produkcyjnej roku. Wyróżnienie dotyczy budowy pierwszego w UE w pełni zintegrowanego centrum rafinacji materiałów do produkcji baterii, które będzie przetwarzać zużyte akumulatory litowo-jonowe w nowe, niskoemisyjne materiały katodowe z zastosowaniem technologii Hydro-to-Cathode®. Rząd Polski przyznał firmie Ascend Elements dofinansowanie w wysokości 32...

TROY, Mich.--(BUSINESS WIRE)--ZIVO Bioscience, Inc. (OTCQB: ZIVO), today issued the following letter to shareholders from Chairman, President and Chief Executive Officer John B. Payne. Dear Fellow Shareholders, I am writing to inform you of a significant and carefully considered decision by the Board of Directors of ZIVO Bioscience, Inc. (“ZIVO” or the “Company”): we intend to deregister the Company’s securities with the Securities and Exchange Commission and cease public reporting. This letter...

WEST SACRAMENTO, Calif.--(BUSINESS WIRE)--Origin Materials, Inc. (“Origin,” “Origin Materials,” or the “Company”) (Nasdaq: ORGN, ORGNW), a technology company with a mission to enable the world’s transition to sustainable materials, today announced financial results for its fourth quarter and full year ended December 31, 2025. Commentary from John Bissell, Origin CEO: "Last year was a challenging one for Origin that also brought meaningful progress. Our commercialization journey has taken longer...